349 results on '"NOBILI, Bruno"'
Search Results
2. Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification
3. CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity
4. Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C
5. The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression
6. The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
7. The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
8. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease
9. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major
10. Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
11. Von Hippel-Lindau–dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster
12. Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study
13. Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties
14. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: A prospective, controlled, multicenter study
15. Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines
16. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function
17. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response
18. Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis
19. Management of Acute Childhood Idiopathic Thrombocytopenic Purpura according to AIEOP Consensus Guidelines: Assessment of Italian Experience
20. Splenectomy in Children With Chronic ITP: Long-Term Efficacy and Relation Between Its Outcome and Responses to Previous Treatments
21. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype
22. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients
23. Bilateral Neuroretinitis in a 6-Year-Old Boy With Acquired Toxoplasmosis
24. Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura
25. SUCCESSFUL UMBILICAL CORD BLOOD TRANSPLANTATION IN A CHILD WITH DYSKERATOSIS CONGENITA AFTER A FLUDARABINE-BASED REDUCED-INTENSITY CONDITIONING REGIMEN
26. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
27. Clinical and molecular evaluation of non-dominant hereditary spherocytosis
28. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
29. Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II)
30. Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency
31. High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis
32. Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition
33. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood
34. Evaluation of body iron status in Italian carriers of beta-thalassemia trait
35. Coinheritance of Gilbert Syndrome Increases the Risk for Developing Gallstones in Patients With Hereditary Spherocytosis: Presented in part at the 40th Annual Meeting of the American Society of Hematology, Miami Beach, FL, December 4-8, 1998 and published in Blood 92:470a, 1998 (abstr, suppl 1) .
36. The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice
37. Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels
38. The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease
39. Moyamoya syndrome in children with neurofibromatosis type 1: Italian–French experience
40. Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C
41. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies
42. The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression
43. ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO
44. Ematologia
45. Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1
46. Studio retrospettivo sulle complicanze emato-oncologiche nella Neurofibromatosi tipo 1 in età pediatrica
47. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study
48. Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy
49. Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency
50. ROBO2 gene variants are associated with familial vesicouretral reflux
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.